ABCB1 is one of the major members of the ABC transporters responsible for the development of MDR and has been highly pursued as a potential target to overcome MDR in many types of cancer cells.[42, 43] Hence, the development of safe and effective ABCB1‐inhibitors has long been a goal to combat MDR. This evidence concerns the gene ABCG2 and cancer.